GPX4 and small cell lung carcinoma: As a control, we could independently confirm that non-neuroendocrine (non-NE) small cell lung cancer (SCLC) presents with a relatively small area under the curve (AUC) and, hence, is highly ferroptosis sensitive in response to the GPX4 small molecule inhibitor ML210 [30].